Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Long-Term Investments: 2020-2022

Historic Long-Term Investments for Sotera Health (SHC) over the last 1 years, with Mar 2022 value amounting to $9.6 million.

  • Sotera Health's Long-Term Investments rose 3.50% to $9.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $9.6 million, marking a year-over-year increase of 3.50%. This contributed to the annual value of $9.4 million for FY2021, which is 30.11% down from last year.
  • Sotera Health's Long-Term Investments amounted to $9.6 million in Q1 2022, which was up 1.54% from $9.4 million recorded in Q4 2021.
  • Sotera Health's 5-year Long-Term Investments high stood at $13.5 million for Q4 2020, and its period low was $9.2 million during Q1 2021.
  • For the 3-year period, Sotera Health's Long-Term Investments averaged around $10.1 million, with its median value being $9.4 million (2021).
  • In the last 5 years, Sotera Health's Long-Term Investments tumbled by 30.11% in 2021 and then rose by 3.50% in 2022.
  • Quarterly analysis of 3 years shows Sotera Health's Long-Term Investments stood at $13.5 million in 2020, then plummeted by 30.11% to $9.4 million in 2021, then grew by 3.50% to $9.6 million in 2022.
  • Its last three reported values are $9.6 million in Q1 2022, $9.4 million for Q4 2021, and $9.4 million during Q3 2021.